<html>

<head>
    <link href="./static/vendor/bootstrap/css/bootstrap.css" rel="stylesheet">
    <link href="./static/css/outliers.css" rel="stylesheet">
    <meta charset="UTF-8">
</head>

<body>
    <div class="container">
        <h1>Static outliers for Kentish Town Central PCN</h1>
        This is some intro text. Please fill in our feedback <a href="https://docs.google.com/forms/d/e/1FAIpQLSeH4ai_qyetAY4UAgZSWGnYQHkXNr9efFBmQvdrBi5uuXvgnQ/viewform?usp=pp_url&entry.2016356131=%20">survey</a>.

        <h2>Prescribing where Kentish Town Central PCN is higher than most</h2>
        <table border="1" class="dataframe table thead-light table-bordered table-sm" id="table_high">
  <thead>
    
    
  <tr><th>BNF Chemical</th>
      <th><abbr title="number of prescribed items containing this chemical">Chemical Items</abbr></th>
      <th>BNF Subparagraph</th>
      <th><abbr title="count of all prescribed items from this subparagraph">Subparagraph Items</abbr></th>
      <th><abbr title="Ratio of chemical items to subparagraph items">Ratio</abbr></th>
      <th><abbr title="Population mean number of chemical items prescribed">Mean</abbr></th>
      <th><abbr title="Standard Deviation">std</abbr></th>
      <th><abbr title="Number of standard deviations prescribeditem count is away from the mean">Z_Score</abbr></th>
      <th>Plots</th>
    </tr></thead>
  
<tbody><tr>
      <th><a href="https://openprescribing.net/analyse/#org=pcn&amp;orgIds=U51577&amp;numIds=1404000AA&amp;denomIds=14.4&amp;selectedTab=summary">Tick-borne encephalitis vaccine</a><button type="button" data-toggle="collapse" data-target="#table_high_0_items" class="btn btn-default btn-xs">&#9776;</button></th>
      <td>1</td>
      <td>Vaccines and antisera</td>
      <td>2494</td>
      <td>0.00</td>
      <td>0.00</td>
      <td>0.00</td>
      <td>21.52</td>
      <td><img class="zoom" src="data:image/png;base64,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"></td>
    </tr>
    <tr id="table_high_0_items" class="collapse"><td colspan="9" class="hiddenRow"><div><a href="https://openprescribing.net/analyse/#org=pcn&amp;orgIds=U51577&amp;numIds=1404000AABDAAAB&amp;denomIds=14.4&amp;selectedTab=summary" target="_blank">TicoVac vacc inj 0.5ml pre-filled syringes : 1</a></div></td></tr><tr>
      <th><a href="https://openprescribing.net/analyse/#org=pcn&amp;orgIds=U51577&amp;numIds=0407020M0&amp;denomIds=4.7.2&amp;selectedTab=summary">Methadone hydrochloride</a><button type="button" data-toggle="collapse" data-target="#table_high_1_items" class="btn btn-default btn-xs">&#9776;</button></th>
      <td>115</td>
      <td>Opioid analgesics</td>
      <td>2638</td>
      <td>0.04</td>
      <td>0.00</td>
      <td>0.00</td>
      <td>14.90</td>
      <td><img class="zoom" src="data:image/png;base64,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"></td>
    </tr>
    <tr id="table_high_1_items" class="collapse"><td colspan="9" class="hiddenRow"><div><a href="https://openprescribing.net/analyse/#org=pcn&amp;orgIds=U51577&amp;numIds=0407020M0AAAEAE&amp;denomIds=4.7.2&amp;selectedTab=summary" target="_blank">Methadone 5mg tablets : 67</a><br><a href="https://openprescribing.net/analyse/#org=pcn&amp;orgIds=U51577&amp;numIds=0407020M0BBAAAE&amp;denomIds=4.7.2&amp;selectedTab=summary" target="_blank">Physeptone 5mg tablets : 48</a></div></td></tr><tr>
      <th><a href="https://openprescribing.net/analyse/#org=pcn&amp;orgIds=U51577&amp;numIds=040701000&amp;denomIds=4.7.1&amp;selectedTab=summary">Other non-opioid analgesic preparations</a><button type="button" data-toggle="collapse" data-target="#table_high_2_items" class="btn btn-default btn-xs">&#9776;</button></th>
      <td>4</td>
      <td>Non-opioid analgesics and compound preparations</td>
      <td>4445</td>
      <td>0.00</td>
      <td>0.00</td>
      <td>0.00</td>
      <td>12.96</td>
      <td><img class="zoom" src="data:image/png;base64,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"></td>
    </tr>
    <tr id="table_high_2_items" class="collapse"><td colspan="9" class="hiddenRow"><div><a href="https://openprescribing.net/analyse/#org=pcn&amp;orgIds=U51577&amp;numIds=040701000BBAJAB&amp;denomIds=4.7.1&amp;selectedTab=summary" target="_blank">4Head sticks : 4</a></div></td></tr><tr>
      <th><a href="https://openprescribing.net/analyse/#org=pcn&amp;orgIds=U51577&amp;numIds=0408010P0&amp;denomIds=4.8.1&amp;selectedTab=summary">Phenobarbital sodium</a><button type="button" data-toggle="collapse" data-target="#table_high_3_items" class="btn btn-default btn-xs">&#9776;</button></th>
      <td>2</td>
      <td>Control of epilepsy</td>
      <td>4818</td>
      <td>0.00</td>
      <td>0.00</td>
      <td>0.00</td>
      <td>12.59</td>
      <td><img class="zoom" src="data:image/png;base64,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"></td>
    </tr>
    <tr id="table_high_3_items" class="collapse"><td colspan="9" class="hiddenRow"><div><a href="https://openprescribing.net/analyse/#org=pcn&amp;orgIds=U51577&amp;numIds=0408010P0AAAAAA&amp;denomIds=4.8.1&amp;selectedTab=summary" target="_blank">Phenobarbital 200mg/1ml solution for injection ampoules : 2</a></div></td></tr><tr>
      <th><a href="https://openprescribing.net/analyse/#org=pcn&amp;orgIds=U51577&amp;numIds=1502010I0&amp;denomIds=15.2.1&amp;selectedTab=summary">Lidocaine</a><button type="button" data-toggle="collapse" data-target="#table_high_4_items" class="btn btn-default btn-xs">&#9776;</button></th>
      <td>30</td>
      <td>Local anaesthetics</td>
      <td>50</td>
      <td>0.60</td>
      <td>0.06</td>
      <td>0.05</td>
      <td>10.70</td>
      <td><img class="zoom" src="data:image/png;base64,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"></td>
    </tr>
  <tr id="table_high_4_items" class="collapse"><td colspan="9" class="hiddenRow"><div><a href="https://openprescribing.net/analyse/#org=pcn&amp;orgIds=U51577&amp;numIds=1502010I0AAAEAE&amp;denomIds=15.2.1&amp;selectedTab=summary" target="_blank">Lidocaine 5% ointment : 30</a></div></td></tr></tbody></table>

        <h2>Prescribing where Kentish Town Central PCN is lower than most</h2>
        <table border="1" class="dataframe table thead-light table-bordered table-sm" id="table_low">
  <thead>
    
    
  <tr><th>BNF Chemical</th>
      <th><abbr title="number of prescribed items containing this chemical">Chemical Items</abbr></th>
      <th>BNF Subparagraph</th>
      <th><abbr title="count of all prescribed items from this subparagraph">Subparagraph Items</abbr></th>
      <th><abbr title="Ratio of chemical items to subparagraph items">Ratio</abbr></th>
      <th><abbr title="Population mean number of chemical items prescribed">Mean</abbr></th>
      <th><abbr title="Standard Deviation">std</abbr></th>
      <th><abbr title="Number of standard deviations prescribeditem count is away from the mean">Z_Score</abbr></th>
      <th>Plots</th>
    </tr></thead>
  
<tbody><tr>
      <th><a href="https://openprescribing.net/analyse/#org=pcn&amp;orgIds=U51577&amp;numIds=1502010J0&amp;denomIds=15.2.1&amp;selectedTab=summary">Lidocaine hydrochloride</a><button type="button" data-toggle="collapse" data-target="#table_low_0_items" class="btn btn-default btn-xs">&#9776;</button></th>
      <td>18</td>
      <td>Local anaesthetics</td>
      <td>50</td>
      <td>0.36</td>
      <td>0.91</td>
      <td>0.07</td>
      <td>-7.65</td>
      <td><img class="zoom" src="data:image/png;base64,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"></td>
    </tr>
    <tr id="table_low_0_items" class="collapse"><td colspan="9" class="hiddenRow"><div><a href="https://openprescribing.net/analyse/#org=pcn&amp;orgIds=U51577&amp;numIds=1502010J0AABQBQ&amp;denomIds=15.2.1&amp;selectedTab=summary" target="_blank">Lidocaine 2% and Chlorhexidine gel : 4</a><br><a href="https://openprescribing.net/analyse/#org=pcn&amp;orgIds=U51577&amp;numIds=1502010J0AABYBY&amp;denomIds=15.2.1&amp;selectedTab=summary" target="_blank">Lidocaine 2.5% / Prilocaine 2.5% cream : 3</a><br><a href="https://openprescribing.net/analyse/#org=pcn&amp;orgIds=U51577&amp;numIds=1502010J0AAELEL&amp;denomIds=15.2.1&amp;selectedTab=summary" target="_blank">Lidocaine 5% medicated plasters : 7</a><br><a href="https://openprescribing.net/analyse/#org=pcn&amp;orgIds=U51577&amp;numIds=1502010J0BBAXAY&amp;denomIds=15.2.1&amp;selectedTab=summary" target="_blank">Xylocaine 1% with Adrenaline 100microg/20ml inj vials : 1</a><br><a href="https://openprescribing.net/analyse/#org=pcn&amp;orgIds=U51577&amp;numIds=1502010J0BDAABQ&amp;denomIds=15.2.1&amp;selectedTab=summary" target="_blank">Instillagel gel : 2</a><br><a href="https://openprescribing.net/analyse/#org=pcn&amp;orgIds=U51577&amp;numIds=1502010J0BEAABY&amp;denomIds=15.2.1&amp;selectedTab=summary" target="_blank">Emla 5% cream : 1</a></div></td></tr><tr>
      <th><a href="https://openprescribing.net/analyse/#org=pcn&amp;orgIds=U51577&amp;numIds=0301030S0&amp;denomIds=3.1.3&amp;selectedTab=summary">Theophylline</a><button type="button" data-toggle="collapse" data-target="#table_low_1_items" class="btn btn-default btn-xs">&#9776;</button></th>
      <td>31</td>
      <td>Theophylline</td>
      <td>69</td>
      <td>0.45</td>
      <td>0.84</td>
      <td>0.15</td>
      <td>-2.63</td>
      <td><img class="zoom" src="data:image/png;base64,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"></td>
    </tr>
    <tr id="table_low_1_items" class="collapse"><td colspan="9" class="hiddenRow"><div><a href="https://openprescribing.net/analyse/#org=pcn&amp;orgIds=U51577&amp;numIds=0301030S0AAAMAM&amp;denomIds=3.1.3&amp;selectedTab=summary" target="_blank">Theophylline 200mg modified-release tablets : 3</a><br><a href="https://openprescribing.net/analyse/#org=pcn&amp;orgIds=U51577&amp;numIds=0301030S0AAAPAP&amp;denomIds=3.1.3&amp;selectedTab=summary" target="_blank">Theophylline 300mg modified-release tablets : 1</a><br><a href="https://openprescribing.net/analyse/#org=pcn&amp;orgIds=U51577&amp;numIds=0301030S0BKABAM&amp;denomIds=3.1.3&amp;selectedTab=summary" target="_blank">Uniphyllin Continus 200mg tablets : 27</a></div></td></tr><tr>
      <th><a href="https://openprescribing.net/analyse/#org=pcn&amp;orgIds=U51577&amp;numIds=0601040I0&amp;denomIds=6.1.4&amp;selectedTab=summary">Glucose</a><button type="button" data-toggle="collapse" data-target="#table_low_2_items" class="btn btn-default btn-xs">&#9776;</button></th>
      <td>14</td>
      <td>Treatment of hypoglycaemia</td>
      <td>26</td>
      <td>0.54</td>
      <td>0.77</td>
      <td>0.09</td>
      <td>-2.53</td>
      <td><img class="zoom" src="data:image/png;base64,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"></td>
    </tr>
    <tr id="table_low_2_items" class="collapse"><td colspan="9" class="hiddenRow"><div><a href="https://openprescribing.net/analyse/#org=pcn&amp;orgIds=U51577&amp;numIds=0601040I0AAADAD&amp;denomIds=6.1.4&amp;selectedTab=summary" target="_blank">Glucose 40% oral gel : 7</a><br><a href="https://openprescribing.net/analyse/#org=pcn&amp;orgIds=U51577&amp;numIds=0601040I0BBABAD&amp;denomIds=6.1.4&amp;selectedTab=summary" target="_blank">GlucoGel 40% gel original : 6</a><br><a href="https://openprescribing.net/analyse/#org=pcn&amp;orgIds=U51577&amp;numIds=0601040I0BEAAAD&amp;denomIds=6.1.4&amp;selectedTab=summary" target="_blank">Dextrogel 40% gel : 1</a></div></td></tr><tr>
      <th><a href="https://openprescribing.net/analyse/#org=pcn&amp;orgIds=U51577&amp;numIds=1305020D0&amp;denomIds=13.5.2&amp;selectedTab=summary">Calcipotriol</a><button type="button" data-toggle="collapse" data-target="#table_low_3_items" class="btn btn-default btn-xs">&#9776;</button></th>
      <td>175</td>
      <td>Preparations for psoriasis</td>
      <td>230</td>
      <td>0.76</td>
      <td>0.87</td>
      <td>0.04</td>
      <td>-2.50</td>
      <td><img class="zoom" src="data:image/png;base64,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"></td>
    </tr>
    <tr id="table_low_3_items" class="collapse"><td colspan="9" class="hiddenRow"><div><a href="https://openprescribing.net/analyse/#org=pcn&amp;orgIds=U51577&amp;numIds=1305020D0AAAAAA&amp;denomIds=13.5.2&amp;selectedTab=summary" target="_blank">Calcipotriol 50micrograms/g ointment : 68</a><br><a href="https://openprescribing.net/analyse/#org=pcn&amp;orgIds=U51577&amp;numIds=1305020D0AAACAC&amp;denomIds=13.5.2&amp;selectedTab=summary" target="_blank">Calcipotriol 50micrograms/ml scalp solution : 16</a><br><a href="https://openprescribing.net/analyse/#org=pcn&amp;orgIds=U51577&amp;numIds=1305020D0AAAFAF&amp;denomIds=13.5.2&amp;selectedTab=summary" target="_blank">Calcipotriol 0.005% / Betamethasone dipropionate 0.05% oint : 21</a><br><a href="https://openprescribing.net/analyse/#org=pcn&amp;orgIds=U51577&amp;numIds=1305020D0AAAGAG&amp;denomIds=13.5.2&amp;selectedTab=summary" target="_blank">Calcipotriol 0.005% / Betamethasone dipropionate 0.05% gel : 18</a><br><a href="https://openprescribing.net/analyse/#org=pcn&amp;orgIds=U51577&amp;numIds=1305020D0AAAIAI&amp;denomIds=13.5.2&amp;selectedTab=summary" target="_blank">Calcipotriol 50microg/Betamethasone diprop 500microg/g foam : 17</a><br><a href="https://openprescribing.net/analyse/#org=pcn&amp;orgIds=U51577&amp;numIds=1305020D0BBAAAA&amp;denomIds=13.5.2&amp;selectedTab=summary" target="_blank">Dovonex 50micrograms/g ointment : 3</a><br><a href="https://openprescribing.net/analyse/#org=pcn&amp;orgIds=U51577&amp;numIds=1305020D0BCAAAF&amp;denomIds=13.5.2&amp;selectedTab=summary" target="_blank">Dovobet ointment : 8</a><br><a href="https://openprescribing.net/analyse/#org=pcn&amp;orgIds=U51577&amp;numIds=1305020D0BEAAAI&amp;denomIds=13.5.2&amp;selectedTab=summary" target="_blank">Enstilar 50micrograms/g / 0.5 mg/g cutaneous foam : 24</a></div></td></tr><tr>
      <th><a href="https://openprescribing.net/analyse/#org=pcn&amp;orgIds=U51577&amp;numIds=1304000F0&amp;denomIds=13.4&amp;selectedTab=summary">Betamethasone valerate</a><button type="button" data-toggle="collapse" data-target="#table_low_4_items" class="btn btn-default btn-xs">&#9776;</button></th>
      <td>323</td>
      <td>Topical corticosteroids</td>
      <td>1873</td>
      <td>0.17</td>
      <td>0.28</td>
      <td>0.04</td>
      <td>-2.45</td>
      <td><img class="zoom" src="data:image/png;base64,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"></td>
    </tr>
  <tr id="table_low_4_items" class="collapse"><td colspan="9" class="hiddenRow"><div><a href="https://openprescribing.net/analyse/#org=pcn&amp;orgIds=U51577&amp;numIds=1304000F0AAAAAA&amp;denomIds=13.4&amp;selectedTab=summary" target="_blank">Betamethasone valerate 0.1% cream : 55</a><br><a href="https://openprescribing.net/analyse/#org=pcn&amp;orgIds=U51577&amp;numIds=1304000F0AAABAB&amp;denomIds=13.4&amp;selectedTab=summary" target="_blank">Betamethasone valerate 0.025% cream : 38</a><br><a href="https://openprescribing.net/analyse/#org=pcn&amp;orgIds=U51577&amp;numIds=1304000F0AABABA&amp;denomIds=13.4&amp;selectedTab=summary" target="_blank">Betamethasone valerate 0.1% ointment : 74</a><br><a href="https://openprescribing.net/analyse/#org=pcn&amp;orgIds=U51577&amp;numIds=1304000F0AABBBB&amp;denomIds=13.4&amp;selectedTab=summary" target="_blank">Betamethasone valerate 0.025% ointment : 17</a><br><a href="https://openprescribing.net/analyse/#org=pcn&amp;orgIds=U51577&amp;numIds=1304000F0AABCBC&amp;denomIds=13.4&amp;selectedTab=summary" target="_blank">Betamethasone valerate 0.1% lotion : 1</a><br><a href="https://openprescribing.net/analyse/#org=pcn&amp;orgIds=U51577&amp;numIds=1304000F0AABDBD&amp;denomIds=13.4&amp;selectedTab=summary" target="_blank">Betamethasone valerate 0.1% scalp application : 92</a><br><a href="https://openprescribing.net/analyse/#org=pcn&amp;orgIds=U51577&amp;numIds=1304000F0AACCCC&amp;denomIds=13.4&amp;selectedTab=summary" target="_blank">Betamethasone valerate 0.1% / Fusidic acid 2% cream : 36</a><br><a href="https://openprescribing.net/analyse/#org=pcn&amp;orgIds=U51577&amp;numIds=1304000F0AACDCD&amp;denomIds=13.4&amp;selectedTab=summary" target="_blank">Betamethasone valerate 0.1% / Clioquinol 3% ointment : 1</a><br><a href="https://openprescribing.net/analyse/#org=pcn&amp;orgIds=U51577&amp;numIds=1304000F0BBAAAA&amp;denomIds=13.4&amp;selectedTab=summary" target="_blank">Betnovate 0.1% cream : 1</a><br><a href="https://openprescribing.net/analyse/#org=pcn&amp;orgIds=U51577&amp;numIds=1304000F0BBADAB&amp;denomIds=13.4&amp;selectedTab=summary" target="_blank">Betnovate RD 0.025% cream : 1</a><br><a href="https://openprescribing.net/analyse/#org=pcn&amp;orgIds=U51577&amp;numIds=1304000F0BBAEBA&amp;denomIds=13.4&amp;selectedTab=summary" target="_blank">Betnovate 0.1% ointment : 3</a><br><a href="https://openprescribing.net/analyse/#org=pcn&amp;orgIds=U51577&amp;numIds=1304000F0BBAHBB&amp;denomIds=13.4&amp;selectedTab=summary" target="_blank">Betnovate RD 0.025% ointment : 1</a><br><a href="https://openprescribing.net/analyse/#org=pcn&amp;orgIds=U51577&amp;numIds=1304000F0BCABCC&amp;denomIds=13.4&amp;selectedTab=summary" target="_blank">Fucibet cream : 2</a><br><a href="https://openprescribing.net/analyse/#org=pcn&amp;orgIds=U51577&amp;numIds=1304000F0BGAABB&amp;denomIds=13.4&amp;selectedTab=summary" target="_blank">Audavate RD 0.025% ointment : 1</a></div></td></tr></tbody></table>

    </div>
    <script src="https://ajax.googleapis.com/ajax/libs/jquery/1.11.3/jquery.min.js"></script>
    <script src="https://maxcdn.bootstrapcdn.com/bootstrap/3.3.5/js/bootstrap.min.js"></script>
</body>

</html>